Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents
a State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
b Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China
c College of Pharmacy and Chemistry, Dali University, Dali 671000, China
d Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, Shanghai 200237, China
e School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
收起